Indian-American doc pays $1,850,000 for performing unnecessary tests, surgeries
Darpan News Desk IANS, 11 Jan, 2023 01:38 PM
New York, Jan 11 (IANS) An Indian-American doctor has agreed to pay approximately $1,850,000 for allegedly billing the government for cataract surgeries and diagnostic tests that were not medically required.
Aarti D. Pandya and her Pandya Practice Group violated the False Claims Act by also performing and billing for tests that were incomplete or of worthless value, and office visits that did not provide the level of service claimed.
"Physicians who perform procedures and tests without a legitimate medical need place profits ahead of patients and subject those patients to unnecessary risk," said US Attorney Ryan K Buchanan in a statement released on Monday.
"This settlement represents our office's commitment to ensuring accountability for physicians who subject patients to unwarranted medical care and waste taxpayer funds," Buchanan said.
From January 1, 2011 to December 31, 2016, Pandya knowingly submitted false claims to federal healthcare programmes for medically unnecessary cataract extraction surgeries and YAG laser capsulotomies, according to a Justice Department release.
The prosecution alleged that Pandya performed these procedures on patients that did not qualify for the procedure under accepted standards of medical practice and, in some cases, caused injury to her patients.
Additionally, it accused Pandya of falsely diagnosing patients with glaucoma to justify unnecessary diagnostic testing and treatment that was billed to Medicare.
The prosecution also said that many of the diagnostic tests that Pandya ordered were not properly performed, were performed on a broken machine, or were not interpreted in the medical record, as required by Medicare.
The Department of Health and Human Services (HHS) imposed in 2019 a payment suspension on the Pandya Practice Group that precluded it from receiving any reimbursement from Medicare for Part B claims.
As part of the settlement of the government's claims in this case, the Pandya Practice Group agreed to forfeit the suspension amount to the government.
The payment suspension will also be lifted as part of the settlement.
To protect federal healthcare programmes and beneficiaries going forward, Pandya and the Pandya Practice Group have entered into a detailed, multi-year Integrity Agreement and Conditional Exclusion Release (IA) with the Office of Inspector General.
"We must assure patients and taxpayers that healthcare is dictated by clinical needs, not fiscal greed," said Keri Farley, Special Agent in Charge of FBI Atlanta. "This settlement should serve as a reminder that the FBI will not tolerate healthcare providers who engage in schemes that defraud the industry and put innocent patients at risk."
British Prime Minister Boris Johnson has shot down speculation that the UK will ease immigration rules for India as part of a Free Trade Agreement (FTA). Negotiations on an Indo-British FTA are scheduled to begin this month.
While Omicron does appear to be less severe compared to Delta, especially in those vaccinated, it does not mean it should be categorised as 'mild' as just like previous variants, Omicron is hospitalising people and it is killing people, WHO Director-General Dr Tedros Adhanom Ghebreyesus said on Thursday.
The president of the United States called out predecessor Donald Trump not by name but by reputation Thursday, marking one year since the Capitol Hill riots with a remarkably simple exhortation to his fellow Americans: to tell and spread and embrace the truth about the 2020 election.
Thursday marks one year since frenzied supporters of Donald Trump, spurred on by the outgoing president's bogus claims of a stolen election, laid siege to the U.S. Capitol in what's now widely seen as an organized effort to prevent Joe Biden from taking over as commander-in-chief.
Eleanor Taylor of the group Aman Lara, an organization that helps Afghans get out of the country, said the little girl named Nafiza was shot and killed while the family was travelling back from a wedding late in the evening of Dec. 10.
The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms.
